This Biotech Investment Opportunity Is More than Just Drugs
When it comes to biotech, it’s easy to get hung up on drugs.Ryan Dinse has spent the last three days covering Synthetic Biology. Or as he likes to call it, ‘synbio’. This is a story that you won’t find anywhere else, and an investment opportunity that can’t be ignored…





